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Introduction
Methylene blue (MB), a widely used inhibitor of NO
activity/production, is also a reduction-oxidation agent
that can act both as a powerful antioxidant and as an
enhancer of the electron transport chain. Furthermore,
it prevents formation of mitochondrial oxygen free radi-
cals and promotes oxygen consumption (Atamna et al.
2010,,Rojas et al. 2012).
Purpose
The aim of the study was to investigate the effects of
chronic (14 days) MB administration on experimental
pain in mice.
Methods
Sixteen Swiss male mice were divided into 2 groups:
control group (n=8) and MB group (n=8); both groups
received daily injections, for 14 days, either with saline
20 Î¼l i.p. (control group) or with MB 5 mg/kg b.w. i.p
(MB group). Nociceptive tests (tail flick and hot plate)
as well as mechanical and thermal withdrawal thresholds
were measured every two days before MB/ saline admin-
istration. Before and two hours after the last dose was
administered (day 14), each group was evaluated for the
nociceptive tests and heat/mechanical hyperalgesia;
results were compared with paired Student’s t test. After
nociceptive tests, the mice received 20 Î¼l of 5% forma-
lin into the upper right lip and the intensity of the oro-
facial pain was assessed. The results were compared
with those from saline group using unpaired Student’s t
test.
Results
Chronic administration of MB increased tail flick and
hot plate latencies (p=0.03, p=0.02). We also noted an
increase in the reaction time for thermal hyperalgesia
assessed by Hargreaves method (p=0.04). As for the for-
malin-induced orofacial pain, MB produced a significant
analgesic effect on both phases (p=0.03).
Conclusion
Our study demonstrates that chronic administration of
MB has analgesic effects on acute nociception as well as
on the orofacial inflammatory pain; further studies must
be conducted in order to elucidate the mechanism by
which the methylene blue exerts its antinociceptive
effect.
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